Okabayashi, Koji <br/><br/>
Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.  [electronic resource] 

 -  Cancer science  Sep 2012 
 - 1617-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1349-7006 
<br/><br/><label>Standard No.: </label>10.1111/j.1349-7006.2012.02355.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Antigens, Neoplasm--genetics<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Squamous Cell--diagnosis<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cloning, Molecular<br/>DNA, Complementary<br/>DNA-Binding Proteins--genetics<br/>Esophageal Neoplasms--diagnosis<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunoglobulin G--blood<br/>Male<br/>Middle Aged<br/>Neoplasm Invasiveness--genetics<br/>Neoplasm Staging<br/>Prognosis